Our first product will be a simple, non-invasive, accurate and inexpensive blood-based
screening test to detect early stage colorectal cancer and adenoma, allowing early detection
and cancer prevention.
Solution
UDX unique and disruptive Colorectal Cancer & Adenoma Test.
The Technology
Combining biotechnology and big data.
METABOLOMICS
Cancer changes the metabolism of human body, which manifests itself through the appearance and increase of differentiated small molecules (<600 Da), so called biomarkers. Metabolic profiling can give an instantaneous snapshot of the physiology of that cell. UDX has identified and quantified a proprietary panel of biomarkers that allows to differentiate cancer and adenoma patients from healthy individuals.
BIOINFORMATICS
Machine learning techniques allow computers to model the world without being explicitly programmed by a previous knowledge, and change their state with new data sets. UDX has developed a machine learning algorithm able to decode millions of data points generated, in order to identify the most relevant biomarkers and perform accurate predictions about the health condition of a patient.
Product Development
UDX is currently completing the first product: the Colorectal Cancer Test
